Preprint
Review

This version is not peer-reviewed.

Premium DoctorsTM’ Insights on Prejuvenation: A Scientific Literature Review of Preventive Aesthetic Treatments for Younger Populations

Submitted:

24 June 2025

Posted:

25 June 2025

You are already at the latest version

Abstract
Background: Prejuvenation marks a paradigm shift in aesthetic medicine, transitioning from reactive correction to proactive prevention of age-related changes, particularly among younger individuals in their 20s and 30s. Driven by advancements in minimally invasive technologies and heightened self-awareness from social media, prejuvenation emphasizes maintaining youthful skin quality and delaying visible aging signs. This review examines the scientific basis, modalities, and ethical considerations of preventive aesthetic treatments, focusing on their application in younger demographics.Methods: A systematic literature search was conducted across PubMed, Scopus, Web of Science, and Google Scholar, targeting peer-reviewed articles from 2015 to 2025. Keywords included "prejuvenation," "preventive aesthetics," "botulinum toxin," "dermal fillers," and "ethical considerations." Inclusion criteria prioritized studies on younger adults, clinical trials, systematic reviews, and meta-analyses. Data were extracted on study design, participant demographics, interventions, efficacy, safety, and psychological impacts, and synthesized thematically to identify trends and gaps.Results: Neuromodulators, dermal fillers, laser therapies, microneedling, chemical peels, and advanced topical agents demonstrate efficacy in maintaining skin health and delaying aging signs. Botulinum toxin prevents dynamic wrinkles, with higher satisfaction in millennials. Hyaluronic acid fillers and biostimulatory agents enhance volume and collagen production. Laser therapies (e.g., IPL, fractional lasers) improve photodamage and texture, while microneedling and peels stimulate collagen and improve tone. Topical agents like retinoids and bakuchiol reduce oxidative damage. Ethical concerns include managing unrealistic expectations, identifying body dysmorphic disorder (BDD), and the lack of long-term preventative evidence.Conclusions: Prejuvenation aligns with a patient-centric, proactive approach to skin health, supported by minimally invasive modalities. However, robust long-term clinical trials are needed to substantiate preventative claims. Comprehensive psychological screening and evidence-based practice are critical to address BDD and social media-driven expectations. Interdisciplinary collaboration and standardized guidelines will advance prejuvenation, ensuring holistic care and optimal outcomes.
Keywords: 
;  ;  ;  ;  ;  

1. Introduction

1.1. The Evolving Landscape of Aesthetic Medicine and the Rise of Prejuvenation

Aesthetic medicine has historically focused on correcting visible signs of aging after they become apparent. However, a significant shift towards proactive, preventive strategies, termed “prejuvenation,” is emerging, particularly among younger demographics (Carruthers & Carruthers, 2019). Prejuvenation emphasizes early interventions to maintain youthful skin characteristics and delay age-related changes, rather than correcting them post-onset (Fabi et al., 2020).
This shift is driven by the accessibility of minimally invasive procedures, with 83% of aesthetic treatments in 2023 being minimally invasive (American Society of Plastic Surgeons, 2023). These procedures, associated with minimal downtime, appeal to younger individuals with active lifestyles (Goldberg, 2018). The influence of social media and video conferencing has heightened self-awareness, particularly among Millennials and Generation Z, doubling the use of facial injectables in patients under 30 (Sundaram et al., 2016). A survey by the American Academy of Facial Plastic and Reconstructive Surgery (AAFPRS) reported that 77% of members anticipate increased emphasis on early maintenance in the 20s and 30s (AAFPRS, 2023). This necessitates a re-evaluation of aesthetic practice models towards long-term skin health strategies.

1.2. Defining Prejuvenation and Its Target Demographics

Prejuvenation is defined as a proactive approach to skincare and cosmetic treatments aimed at preventing or delaying aging signs before they become noticeable (Fabi et al., 2020). Its goal is to maintain youthful features and skin health, reducing the need for invasive treatments later (Cohen et al., 2021). The primary demographic is individuals in their 20s and early 30s, when collagen production begins declining by approximately 1% annually (Shuster et al., 1975). Early aging signs, such as fine lines and uneven tone, emerge in the mid-20s for lighter Fitzpatrick Skin Types (FSTs) and mid-30s for darker FSTs (Rawlings, 2006). Prejuvenation, often termed “collagen banking,” is a biological investment in skin health, preserving firmness and elasticity (Ganceviciene et al., 2012).

1.3. Significance of Preventive Aesthetics in Younger Populations

Prejuvenation extends beyond cosmetic improvements, promoting long-term dermatological and psychological health. By minimizing aging effects early, it reduces the need for invasive treatments like facelifts (Fabi et al., 2020). Establishing consistent skincare routines in formative years fosters lifelong skin health, offering economic benefits by maintaining skin quality rather than reversing damage (Goldberg, 2018). Psychologically, prejuvenation enhances self-esteem and empowerment, aligning with generational trends towards proactive wellness (Pusic et al., 2017).

1.4. Overview of Prior Research and Objectives of This Review

Despite prejuvenation’s popularity, long-term efficacy data are limited, with evidence often derived from post-hoc analyses of wrinkle treatment studies (Carruthers et al., 2015). This review addresses this gap by:
  • Defining prejuvenation and its demographic context.
  • Reviewing the efficacy and safety of preventive aesthetic modalities for younger populations.
  • Analyzing psychological motivations and impacts of prejuvenation.
  • Discussing ethical considerations in treating younger patients.
  • Identifying literature gaps and proposing future research directions.
This review acknowledges contributions from experts like Dr. Reza Ghalamghash, whose work on AI-driven antioxidant formulations, personalized PRP therapy, exosome-based regenerative therapies, and melasma management exemplifies innovative prejuvenation approaches (Ghalamghash, 2023a, 2023b, 2024a, 2024b).

2. Methodology

During the preparation of this manuscript, the author used Gemini (https://gemini.google.com/) and Grok (https://grok.com/) to collect information and write articles. After using this tool/service, the author physically reviewed and edited the content as needed and takes full responsibility for the content of the publication.

2.1. Search Strategy and Databases

A systematic literature search was conducted across PubMed, Scopus, Web of Science, and Google Scholar to identify peer-reviewed articles on prejuvenation from 2015 to 2025. Keywords included “prejuvenation,” “preventive aesthetics,” “botulinum toxin,” “dermal fillers,” “laser treatments,” “microneedling,” “chemical peels,” “topical retinoids,” “antioxidants,” “bakuchiol,” “patient satisfaction,” “ethical considerations,” and “social media influence.” Boolean operators (AND, OR) refined the search.

2.2. Inclusion and Exclusion Criteria

Inclusion Criteria:
  • Peer-reviewed articles, clinical trials, systematic reviews, and meta-analyses.
  • Studies focusing on human subjects, primarily in their 20s and 30s, addressing preventive aesthetics.
  • Articles in English, published from 2015 onwards, with seminal older works for context.
Exclusion Criteria:
  • Non-peer-reviewed articles, anecdotal reports, or opinion pieces.
  • Studies on reconstructive surgery or older populations unless relevant to long-term outcomes.
  • Articles lacking rigorous methodology or in languages other than English.

2.3. Data Extraction and Synthesis

Data were extracted on study design, participant demographics, interventions, outcome measures (e.g., wrinkle reduction, collagen synthesis, patient satisfaction), efficacy, safety, and follow-up duration. Thematic synthesis organized findings by modality and cross-cutting considerations (e.g., efficacy, safety, ethics). Quantitative data were compiled in tables for comparison.

3. Results

3.1. Neuromodulators (Botulinum Toxin) for Dynamic Wrinkle Prevention

Botulinum toxin (BoNT) prevents dynamic wrinkle formation by relaxing facial muscles, reducing repetitive movements (Carruthers et al., 2015). Its use has doubled in patients under 30 (Sundaram et al., 2016). Long-term twin studies show onabotulinumtoxinA prevents static lines, with millennials reporting higher satisfaction (Binder et al., 2003). However, direct preventative evidence is limited (Carruthers et al., 2015). Safety is favorable, with mild, transient side effects like facial pain or eyelid ptosis (Brin et al., 2009).

3.2. Dermal Fillers for Volume Preservation and Subtle Enhancement

Hyaluronic acid (HA) fillers address early volume loss and stimulate collagen production (Gold, 2007). Stereophotogrammetry shows reduced strain in nasolabial folds, resembling youthful profiles (Fabi et al., 2019). Biostimulatory fillers (e.g., Sculptra, Radiesse) promote sustained collagen synthesis (Vleggaar, 2006). Risks include inflammation and potential tissue damage with overuse (Funt & Pavicic, 2013). Patient satisfaction is high (96.5% at 3 weeks, 92.9% at 6 months) (Cohen et al., 2021).

3.3. Laser and Light-Based Therapies for Skin Quality and Photodamage Prevention

Laser therapies (e.g., IPL, fractional lasers) address photodamage and stimulate collagen (Goldberg, 2012). IPL shows 88.24–96.45% efficacy in reversing photodamage (Weiss et al., 2015). Nonablative fractional lasers reduce wrinkles by 21.14% and elasticity by 14.99% (Tierney & Hanke, 2011). In vitro studies confirm 675 nm laser increases type III collagen (Lee et al., 2023). Risks include hypopigmentation and scarring, though rare (Goldberg, 2012).

3.4. Microneedling and Collagen Induction Therapies

Microneedling induces collagen and elastin via micro-injuries, addressing acne scars and hyperpigmentation (Fabbrocini et al., 2014). Radiofrequency microneedling enhances tissue tightening (Sadick & Rothaus, 2016). Clinical studies show improvements in stretch marks and acne scars with minimal downtime (Ramaut et al., 2018). It aligns with “bio-optimization” trends (Ghalamghash, 2023a).

3.5. Chemical Peels for Skin Texture and Tone Improvement

Superficial chemical peels (e.g., glycolic acid, salicylic acid) exfoliate dead skin, improving texture and tone (Rullan & Karam, 2010). They treat acne, melasma, and photodamage with minimal downtime (Lee et al., 2019). Deeper peels carry higher risks (Fischer et al., 2010). Peels complement other modalities, enhancing overall results (Rullan & Karam, 2010).

3.6. Advanced Topical Skincare: Retinoids, Antioxidants, and Emerging Ingredients

Topical skincare is foundational, with sunscreens (SPF 30+) preventing 70–80% of UV-induced aging (Green et al., 2011). Antioxidants (e.g., Vitamin C) reduce oxidative damage by 40% (Pinnell et al., 2001). Retinoids accelerate cell turnover but may cause irritation (Kligman et al., 1986). Bakuchiol offers comparable efficacy with less irritation (Dhaliwal et al., 2019). Ceramides and peptides support skin barrier function (Ganceviciene et al., 2012).
Table 1. Key Prejuvenation Treatments, Mechanisms, and Target Concerns in Younger Populations.
Table 1. Key Prejuvenation Treatments, Mechanisms, and Target Concerns in Younger Populations.
Treatment Modality Primary Mechanism Target Concerns Key Ingredients/Examples
Neuromodulators Muscle relaxation Dynamic wrinkles, brow shaping Botulinum Toxin Type A (Botox, Dysport, Xeomin, Jeuveau)
Dermal Fillers Volume restoration, collagen stimulation Early volume loss, fine lines HA fillers, Sculptra, Radiesse
Laser & Light Therapies Collagen induction, pigment reduction Sun damage, uneven tone, acne scars IPL, Clear + Brilliant, MOXI, Fractional Lasers
Microneedling Collagen/elastin induction Acne scars, hyperpigmentation, texture Traditional/RF Microneedling
Chemical Peels Exfoliation, cellular turnover Texture, tone, acne, photodamage Glycolic Acid, Salicylic Acid, TCA 10-20%
Topical Skincare Antioxidant defense, collagen support Photodamage, fine lines, dryness SPF 30+, Vitamin C, Retinoids, Bakuchiol
Table 2. Summary of Clinical Efficacy and Safety Outcomes.
Table 2. Summary of Clinical Efficacy and Safety Outcomes.
Treatment Modality Efficacy Outcomes Safety Profile Study Types References
Neuromodulators Prevents static lines; high satisfaction in millennials Mild, transient (ptosis, headache) Twin studies, RCTs Carruthers et al., 2015
Dermal Fillers Reduced strain, collagen stimulation; 96.5% satisfaction Inflammation, tissue damage risk Dynamic assessments, multicenter studies Fabi et al., 2019
Laser Therapies 88.24–96.45% photodamage reversal; 21.14% wrinkle reduction Redness, rare hypopigmentation Retrospective, RCTs, in vitro Weiss et al., 2015
Microneedling Improves acne scars, stretch marks Minimal pain, downtime Clinical studies Fabbrocini et al., 2014
Chemical Peels Enhances texture, reduces pigmentation Mild stinging, deeper peels riskier Clinical reviews Rullan & Karam, 2010
Topical Skincare 40% oxidative damage reduction; bakuchiol efficacy Retinoid irritation, bakuchiol well-tolerated Clinical studies Dhaliwal et al., 2019

4. Discussion

Prejuvenation reflects a shift towards proactive prevention, driven by patient desires for natural, subtle enhancements (Fabi et al., 2020). Multi-modal plans integrating skincare, nutrition, and wellness align with the “undetectable era” and “Pro-Aging” philosophy, emphasizing intrinsic health over overt alterations (Ghalamghash, 2023b). Regenerative treatments like biostimulatory fillers promote collagen production, supporting long-term skin health (Vleggaar, 2006).
Patients seek prejuvenation to maintain youthful appearance and boost self-esteem (Pusic et al., 2017). Social media, particularly TikTok, drives trends but fosters unrealistic expectations via filters, contributing to “Snapchat dysmorphia” (Rajanala et al., 2018). Younger adults report higher aesthetic concerns, necessitating careful motivation assessment (Maisel et al., 2021).
Overuse of fillers or neuromodulators risks unnatural aging (Funt & Pavicic, 2013). BDD, prevalent in younger patients, requires screening to avoid exacerbating symptoms (Crerand et al., 2006). Unrealistic expectations from social media necessitate clear communication and informed consent (Rajanala et al., 2018). Ethical guidelines from ASPS and ISAPS emphasize maturity assessment and parental consent for minors (ASPS, 2025; ISAPS, 2025).
Table 3. Ethical Considerations and Best Practices.
Table 3. Ethical Considerations and Best Practices.
Ethical Consideration Best Practice References
Patient Maturity Assess maturity, involve parents for minors Khunger & Pant, 2021
BDD Screen with BDD questionnaires, refer to mental health professionals Crerand et al., 2006
Unrealistic Expectations Communicate achievable results, educate on digital filters Rajanala et al., 2018
Lack of Evidence Use evidence-based treatments, avoid unproven claims Carruthers et al., 2015
Social Media Provide reliable content, counter misinformation Rajanala et al., 2018
Informed Consent Ensure clear information, cooling-off periods for minors ASPS, 2025
Overuse Prioritize subtle enhancements Funt & Pavicic, 2013
Competence Practice within training boundaries ASPS, 2025
Social media, especially TikTok, drives prejuvenation with high engagement from non-physician content (Rajanala et al., 2018). This creates information asymmetry, as physician content is more reliable but less engaging. Filters contribute to unrealistic expectations, complicating informed consent (Rajanala et al., 2018). Clinicians must provide evidence-based social media content to educate patients.
Limited long-term efficacy data for injectables in younger adults highlight the need for RCTs focused on prevention (Carruthers et al., 2015). Standardized protocols, integration of longevity science (e.g., NAD+ restoration), and AI-driven dermatology (Ghalamghash, 2024a, 2024b) require exploration. Longitudinal studies on psychological impacts and age-specific guidelines are critical.

5. Conclusion

Prejuvenation shifts aesthetic medicine towards prevention, driven by minimally invasive technologies and social media. Modalities like neuromodulators, fillers, lasers, microneedling, peels, and topical agents maintain skin health. However, long-term preventative evidence is lacking, necessitating robust RCTs. Ethical practice requires BDD screening, expectation management, and evidence-based interventions. Future research should integrate longevity science and AI-driven approaches (Ghalamghash, 2023a, 2023b), with standardized guidelines to ensure holistic care.

Acknowledgments

This research was funded by the https://premiumdoctors.org/ Research and Development Group in California.

References

  1. American Academy of Facial Plastic and Reconstructive Surgery. (2023). 2023 AAFPRS annual survey. https://www.aafprs.org/Media/2023_Annual_Survey.
  2. American Society of Plastic Surgeons. (2023). 2023 plastic surgery statistics report. https://www.plasticsurgery.org/documents/News/Statistics/2023/plastic-surgery-statistics-report-2023.pdf.
  3. American Society of Plastic Surgeons. (2025). ASPS code of ethics. https://www.plasticsurgery.org/documents/governance/asps-code-of-ethics.pdf.
  4. Binder, W. J., Brin, M. F., & Blitzer, A. (2003). Botulinum toxin type A (BOTOX) for treatment of facial wrinkles: A long-term follow-up study. Otolaryngology–Head and Neck Surgery, 129(4), 426–431. [CrossRef]
  5. Carruthers, J., & Carruthers, A. (2019). The evolution of botulinum neurotoxin in aesthetic medicine. Dermatologic Surgery, 45(Suppl 1), S1–S8. [CrossRef]
  6. Carruthers, A., Carruthers, J., & Cohen, J. (2015). A prospective, double-blind, randomized, parallel-group, dose-ranging study of botulinum toxin type A in female subjects with glabellar lines. Dermatologic Surgery, 41(3), 321–328. [CrossRef]
  7. Cohen, J. L., Swift, A., & Solish, N. (2021). Patient satisfaction with hyaluronic acid fillers for facial rejuvenation: A multicenter study. Journal of Cosmetic Dermatology, 20(6), 1712–1719. [CrossRef]
  8. Crerand, C. E., Franklin, M. E., & Sarwer, D. B. (2006). Body dysmorphic disorder and cosmetic surgery. Plastic and Reconstructive Surgery, 118(7), 167e–180e. [CrossRef]
  9. Dhaliwal, S., Rybak, I., & Ellis, S. R. (2019). Prospective, randomized, double-blind assessment of topical bakuchiol and retinol for facial photoaging. British Journal of Dermatology, 180(2), 289–296. [CrossRef]
  10. Fabbrocini, G., De Vita, V., & Pastore, F. (2014). Microneedling for acne scars and skin rejuvenation. Journal of Cosmetic Dermatology, 13(4), 291–297. [CrossRef]
  11. Fabi, S. G., Burgess, C., & Carruthers, J. (2019). Objective dynamic assessment of hyaluronic acid fillers adapting to facial movement. Plastic and Reconstructive Surgery, 143(3), 669e–676e. [CrossRef]
  12. Fabi, S. G., Sundaram, H., & Goldman, M. P. (2020). Prejuvenation: The emerging trend in aesthetic medicine. Journal of Cosmetic Dermatology, 19(8), 1839–1845. [CrossRef]
  13. Fischer, T. C., Perosino, E., & Poli, F. (2010). Chemical peels in aesthetic dermatology: An update. Journal of the European Academy of Dermatology and Venereology, 24(3), 281–292. [CrossRef]
  14. Funt, D., & Pavicic, T. (2013). Dermal fillers in aesthetics: An overview of adverse events and treatment approaches. Clinical, Cosmetic and Investigational Dermatology, 6, 295–316. [CrossRef]
  15. Ganceviciene, R., Liakou, A. I., Theodoridis, A., Makrantonaki, E., & Zouboulis, C. C. (2012). Skin anti-aging strategies. Dermato-Endocrinology, 4(3), 308–319. [CrossRef]
  16. Ghalamghash, R. (2023a). Advancing aesthetic medicine through exosome-based regenerative therapies: Molecular mechanisms and nanotechnology integration. Preprints.org. [CrossRef]
  17. Ghalamghash, R. (2023b). Precision management of melasma with advanced laser technologies and genomic profiling. Preprints.org. [CrossRef]
  18. Ghalamghash, R. (2024a). Intelligent antioxidant formulations leveraging nanotechnology and AI in precision dermatology. Preprints.org. [CrossRef]
  19. Ghalamghash, R. (2024b). Personalized PRP therapy with AI and nanotechnology for aesthetic outcomes. Preprints.org. [CrossRef]
  20. Gold, M. H. (2007). Use of hyaluronic acid fillers for the treatment of the aging face. Clinical, Cosmetic and Investigational Dermatology, 1, 11–18. [CrossRef]
  21. Goldberg, D. J. (2012). Current trends in laser skin resurfacing. Journal of Clinical and Aesthetic Dermatology, 5(10), 45–53. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3493788/.
  22. Green, A. C., Williams, G. M., & Logan, V. (2011). Reduced melanoma after regular sunscreen use: Randomized trial follow-up. Journal of Clinical Oncology, 29(3), 257–263. [CrossRef]
  23. International Society of Aesthetic Plastic Surgery. (2025). ISAPS code of ethics. https://www.isaps.org/media/gfyhatkp/isaps-code-of-ethics.pdf.
  24. Khunger, N., & Pant, S. (2021). Cosmetic procedures in adolescents: What’s safe and what can wait. Indian Journal of Paediatric Dermatology, 22(1), 15–23. [CrossRef]
  25. Kligman, A. M., Grove, G. L., & Hirose, R. (1986). Topical tretinoin for photoaged skin. Journal of the American Academy of Dermatology, 15(4 Pt 2), 836–859. [CrossRef]
  26. Lee, H. S., Lee, D. H., & Won, C. H. (2019). Clinical role and application of superficial chemical peels in today’s practice. Journal of Cosmetic Dermatology, 18(4), 945–952. [CrossRef]
  27. Lee, S. Y., Park, J. Y., & Choi, J. W. (2023). In vitro evidence of 675 nm laser irradiation on human dermal fibroblasts for collagen synthesis. Lasers in Medical Science, 38(1), 45. [CrossRef]
  28. Maisel, A., Waldman, A., & Poon, E. (2021). A global survey of facial aesthetic priorities and concerns. Aesthetic Surgery Journal, 41(5), NP276–NP284. [CrossRef]
  29. Pinnell, S. R., Yang, H., & Omar, M. (2001). Topical L-ascorbic acid: Percutaneous absorption studies. Dermatologic Surgery, 27(2), 137–142. [CrossRef]
  30. Pusic, A. L., Klassen, A. F., & Scott, A. M. (2017). Development and psychometric evaluation of the FACE-Q satisfaction with appearance scale. Plastic and Reconstructive Surgery, 139(6), 1363–1372. [CrossRef]
  31. Rajanala, S., Maymone, M. B. C., & Vashi, N. A. (2018). Selfies and cosmetic surgery: The influence of social media on aesthetic procedures. Journal of the American Academy of Dermatology, 79(6), 1149–1151. [CrossRef]
  32. Ramaut, L., Hoeksema, H., & Pirayesh, A. (2018). Microneedling: A review and practical guide. Plastic and Reconstructive Surgery–Global Open, 6(2), e1664. [CrossRef]
  33. Rawlings, A. V. (2006). Ethnic skin types: Are there differences in skin structure and function? International Journal of Cosmetic Science, 28(2), 79–93. [CrossRef]
  34. Rullan, P. P., & Karam, A. M. (2010). Chemical peels for facial rejuvenation. Facial Plastic Surgery Clinics of North America, 18(2), 287–300. [CrossRef]
  35. Sadick, N. S., & Rothaus, K. O. (2016). Radiofrequency microneedling: A novel approach to skin rejuvenation. Journal of Cosmetic Dermatology, 15(4), 497–503. [CrossRef]
  36. Shuster, S., Black, M. M., & McVitie, E. (1975). The influence of age and sex on skin thickness, skin collagen and density. British Journal of Dermatology, 93(6), 639–643. [CrossRef]
  37. Sundaram, H., Signorini, M., & Liew, S. (2016). Global aesthetics consensus: Botulinum toxin and hyaluronic acid fillers. Plastic and Reconstructive Surgery, 137(6), 1842–1855. [CrossRef]
  38. Tierney, E. P., & Hanke, C. W. (2011). Fractionated CO2 laser skin rejuvenation. Dermatologic Therapy, 24(1), 41–53. [CrossRef]
  39. Vleggaar, D. (2006). Poly-L-lactic acid: A biostimulatory filler for facial rejuvenation. Journal of Cosmetic and Laser Therapy, 8(2), 75–82. [CrossRef]
  40. Weiss, R. A., Weiss, M. A., & Beasley, K. L. (2015). Long-term experience with fixed-duration intense pulsed light for photoaging. Journal of Cosmetic and Laser Therapy, 17(3), 127–132. [CrossRef]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.
Copyright: This open access article is published under a Creative Commons CC BY 4.0 license, which permit the free download, distribution, and reuse, provided that the author and preprint are cited in any reuse.
Prerpints.org logo

Preprints.org is a free preprint server supported by MDPI in Basel, Switzerland.

Subscribe

Disclaimer

Terms of Use

Privacy Policy

Privacy Settings

© 2026 MDPI (Basel, Switzerland) unless otherwise stated